Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Identification of ICAD-derived peptides capable of inhibiting caspase-activated DNase.

Kutscher D, Pingoud A, Jeltsch A, Meiss G.

FEBS J. 2012 Aug;279(16):2917-28. doi: 10.1111/j.1742-4658.2012.08673.x. Epub 2012 Jul 10.

2.

Large complex formation of the inhibitor of caspase-activated DNase.

Kanouchi H, Nishizaki H, Minatogawa Y, Toné S.

Apoptosis. 2005 May;10(3):651-6.

PMID:
15909126
3.

A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD.

Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S.

Nature. 1998 Jan 1;391(6662):43-50. Erratum in: Nature 1998 May 28;393(6683):396.

PMID:
9422506
4.

Identification of regulatory and catalytic domains in the apoptosis nuclease DFF40/CAD.

Inohara N, Koseki T, Chen S, Benedict MA, Núñez G.

J Biol Chem. 1999 Jan 1;274(1):270-4.

5.

Enzymatic active site of caspase-activated DNase (CAD) and its inhibition by inhibitor of CAD.

Sakahira H, Takemura Y, Nagata S.

Arch Biochem Biophys. 2001 Apr 1;388(1):91-9.

PMID:
11361146
6.
7.

Co-translational folding of caspase-activated DNase with Hsp70, Hsp40, and inhibitor of caspase-activated DNase.

Sakahira H, Nagata S.

J Biol Chem. 2002 Feb 1;277(5):3364-70. Epub 2001 Nov 27.

8.

Oligomerization state of the DNA fragmentation factor in normal and apoptotic cells.

Lechardeur D, Dougaparsad S, Nemes C, Lukacs GL.

J Biol Chem. 2005 Dec 2;280(48):40216-25. Epub 2005 Oct 3.

9.

Structure of the CAD domain of caspase-activated DNase and interaction with the CAD domain of its inhibitor.

Uegaki K, Otomo T, Sakahira H, Shimizu M, Yumoto N, Kyogoku Y, Nagata S, Yamazaki T.

J Mol Biol. 2000 Apr 14;297(5):1121-8.

PMID:
10764577
10.

Functional differences of two forms of the inhibitor of caspase-activated DNase, ICAD-L, and ICAD-S.

Sakahira H, Enari M, Nagata S.

J Biol Chem. 1999 May 28;274(22):15740-4.

11.

Specific chaperone-like activity of inhibitor of caspase-activated DNase for caspase-activated DNase.

Sakahira H, Iwamatsu A, Nagata S.

J Biol Chem. 2000 Mar 17;275(11):8091-6.

12.

Determinants of the nuclear localization of the heterodimeric DNA fragmentation factor (ICAD/CAD).

Lechardeur D, Drzymala L, Sharma M, Zylka D, Kinach R, Pacia J, Hicks C, Usmani N, Rommens JM, Lukacs GL.

J Cell Biol. 2000 Jul 24;150(2):321-34.

13.

Structural mechanism for inactivation and activation of CAD/DFF40 in the apoptotic pathway.

Woo EJ, Kim YG, Kim MS, Han WD, Shin S, Robinson H, Park SY, Oh BH.

Mol Cell. 2004 May 21;14(4):531-9.

14.

Identification and characterization of the human inhibitor of caspase-activated DNase gene promoter.

Omata K, Suzuki R, Masaki T, Miyamura T, Satoh T, Suzuki T.

Apoptosis. 2008 Jul;13(7):929-37. doi: 10.1007/s10495-008-0223-8.

15.

Status epilepticus leads to the degradation of the endogenous inhibitor of caspase-activated DNase in rats.

Kondratyev A, Selby D, Gale K.

Neurosci Lett. 2002 Feb 22;319(3):145-8.

PMID:
11834314
16.

Caspase-activated DNase/DNA fragmentation factor 40 mediates apoptotic DNA fragmentation in transient cerebral ischemia and in neuronal cultures.

Cao G, Pei W, Lan J, Stetler RA, Luo Y, Nagayama T, Graham SH, Yin XM, Simon RP, Chen J.

J Neurosci. 2001 Jul 1;21(13):4678-90.

18.

Structure of the heterodimeric complex between CAD domains of CAD and ICAD.

Otomo T, Sakahira H, Uegaki K, Nagata S, Yamazaki T.

Nat Struct Biol. 2000 Aug;7(8):658-62.

PMID:
10932250
19.

Identification and developmental expression of inhibitor of caspase-activated DNase (ICAD) in Drosophila melanogaster.

Mukae N, Yokoyama H, Yokokura T, Sakoyama Y, Sakahira H, Nagata S.

J Biol Chem. 2000 Jul 14;275(28):21402-8.

20.

Genetic analysis of the short splice variant of the inhibitor of caspase-activated DNase (ICAD-S) in chicken DT40 cells.

Ageichik AV, Samejima K, Kaufmann SH, Earnshaw WC.

J Biol Chem. 2007 Sep 14;282(37):27374-82. Epub 2007 Jul 6.

Items per page

Supplemental Content

Write to the Help Desk